摘要:
A base end 12a of an arc tube unit 12 is inserted in a glass tube 50 which is previously fixed to an insulating plug unit 14, and a shroud tube 18 and the glass tube 50 are then bonded and fixed to each other in such a state that an amount of insertion of the arc tube unit 12 is regulated in order to set a dimension L between an optical reference plane Po of the insulating plug unit 14 and the tip position of a bar-shaped electrode 26B of an arc tube 16 to be a predetermined set dimension Lo. Consequently, the arc tube unit 12 can be fixed and supported on the insulating plug unit 14 with a simple structure in a simple process, and furthermore, it is possible to eliminate a possibility that the shroud tube 18 might be damaged, for example, broken by the fastening force of a metal band as in the conventional art.
摘要:
The invention relates to a powdered milk product includes angiogenin and/or angiogenin hydrolysate in an amount of 1.4 to 24 mg/15 g, and lactoperoxidase and/or lactoperoxidase hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.35 to 10.
摘要:
Skin quality is improved by orally administering a cystatin and/or a degraded product of cystatin in an amount of 10 μg/day or more per adult, or applying a composition that includes a cystatin and/or a degraded product of cystatin in an amount of 0.001 to 2 wt % based on a total amount of the composition.
摘要:
An example game apparatus stores a state of a game during execution as execution state information in a memory, and stores a captured image of the game screen by bringing it into correspondence with the execution state information in the memory. Furthermore, during execution of the game, the captured image is displayed on a lower LCD while the game screen is displayed on an upper LCD. In a state that the game screen and the captured image are thus displayed, a selecting operation from a user is accepted. Then, by using the execution state information which is brought into correspondence with the captured image selected in response to a selecting operation, the state of the game is restored.
摘要:
In a light emitting module, a semiconductor light emitting element emits short-wavelength visible light. A plurality of the semiconductor light emitting elements are provided side by side on the same flat surface. The light wavelength conversion member contains a first phosphor and a second phosphor, the wavelength of the light emitted after the wavelength thereof has been converted by either of the two being different from the excitation wavelength for the other. The first phosphor emits yellow light by exciting the short-wavelength visible light. The second phosphor emits blue light by exciting the short-wavelength visible light. The first phosphor does not include the wavelength range of the blue light in the excitation wavelength range thereof. The light wavelength conversion member is cured after being potted so as to integrally cover the plurality of the semiconductor light emitting elements.
摘要:
A cleaning blade is disposed in an abutting relation with an image bearing body and configured to remove residual developer material from the image bearing body. The cleaning blade has a tan δ peak temperature equal to or higher than 8.6° C. and lower than 45° C., and any one of a Young's modulus equal to or higher than 13 Mpa and lower than 140 Mpa, a tensile strength equal to or higher than 37.3 Mpa and lower than 76 Mpa, a hardness equal to or higher than 83° and lower than 97°, and a tearing strength equal to or higher than 59 kgf/cm and lower than 118 kgf/cm.
摘要:
To provide a fat accumulation inhibitor and a food or drink for inhibiting fat accumulation, a visceral fat accumulation inhibitor and a food or drink for inhibiting visceral fat accumulation, or an agent for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood and a food or drink for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood.A fat accumulation inhibitor for a fat cell, which comprises a milk-derived phospholipid as an active ingredient, and a food or drink for inhibiting fat accumulation in a fat cell, which comprises a milk-derived phospholipid. A visceral fat accumulation inhibitor comprising a sphingosine-containing phospholipid or a derivative thereof as an active ingredient, and a food or drink for inhibiting visceral fat accumulation. An agent for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood, which comprises a sphingosine-containing phospholipid or a derivative thereof as an active ingredient, and a food or drink for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood.
摘要:
Disclosed is a sintered silicon carbide body with a high thermal conductivity which has a thermal conductivity of not less than 150 W/m.multidot.K, which is produced by(a) mixing(1) a first silicon carbide powder having a mean grain size of from 0.1 to 10 .mu.m with(2) a second silicon carbide powder having a mean grain size of not greater than 0.1 .mu.m prepared by(2-1) introducing a starting gas composed of a silane compound or silicon halide and a hydrocarbon into a plasma of a non-oxidative atmosphere, and(2-2) conducting gas phase reaction between the silane compound or silicon halide and the hydrocarbon while controlling the pressure of the reaction system within the range of from less than 1 atom to 0.1 torr, and(3) optionally, a carbon powder which is required for reducing oxides contained in both the first and second silicon carbide powders,(b) optioanlly reducing the oxides with the carbon, and(c) heating the resulting mixture for sintering. Also, processes of producing the same are disclosed.
摘要:
The invention relates to a cheese includes angiogenin and/or angiogenin hydrolysate in an amount of 6.5 mg/100 g to 160 mg/100 g, and lactoperoxidase and/or lactoperoxidase hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.3 to 33.
摘要:
The invention relates to a cheese includes angiogenin and/or angiogenin hydrolysate in an amount of 6.5 mg/100 g to 160 mg/100 g, and cystatin and/or cystatin hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.02 to 1.6.